|Day Low/High||324.28 / 330.00|
|52 Wk Low/High||249.17 / 388.67|
Biogen (NASDAQ: BIIB) presented new data demonstrating that earlier initiation of treatment with SPINRAZA ® (nusinersen) may improve motor function outcomes in infants and children with spinal muscular atrophy...
I will be watching Friday's small underperformance in the small caps.
Biogen Inc. (NASDAQ:BIIB) today announced it will report third quarter 2017 financial results on Tuesday, October 24, 2017, before the financial markets open.
Biogen (NASDAQ: BIIB) announced the appointment of Camille Lee as Senior Vice President, Alzheimer's Therapeutic Area, effective today.
Biogen (NASDAQ: BIIB) announced today the appointment of Dr.
Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Morgan Stanley 15 th Annual Global Healthcare Conference.
Biogen (NASDAQ: BIIB) today announced results from a recently conducted analysis of the long-term extension (LTE) of its ongoing Phase 1b study of aducanumab, the company's investigational treatment for early...
The European Commission (EC) granted a marketing authorization for IMRALDI ® (also known as SB5), an adalimumab biosimilar referencing Humira ®.
'Biogen has a relatively under-leverage balance sheet, and we expect [free cash flow yield] and US cash to grow.'
Pfizer post earnings beat.
Biogen (NASDAQ:BIIB) today announced the appointment of Anabella Villalobos, Ph.
The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.
The S&P 500 and Nasdaq end at records.
Novavax, Medicines Co. and Biogen were among the biotech stock movers in premarket trading on July 25.
These disparate names seem to fit quite well with the investment approach of the Oracle of Omaha.
U.S. stock futures turn higher on Tuesday following earnings from Alphabet.
Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2017 financial results, including: Total revenues of $3.
Biogen (NASDAQ: BIIB) announced today the appointment of Alisha A.
Wall Street's first glimpse at the second quarter.
Here are the activist investor's next potential targets.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.